Physician-directed ED treatment, matched to you

Sildenafil is a PDE5 inhibitor that increases blood flow to support erectile function, taken as-needed before sexual activity.

Tadalafil is a longer-acting PDE5 inhibitor, sometimes called a weekend option due to its extended window of effect compared to shorter-acting alternatives.

A daily chewable combining two PDE5 inhibitors at low, steady doses for spontaneity without single-dose timing.

Pairs tadalafil with pycnogenol, a plant-derived antioxidant sometimes studied alongside PDE5 therapy for vascular support.

Combines tadalafil with bremelanotide, a melanocortin-receptor agonist sometimes used for libido support, alongside pycnogenol.

A higher-dose sildenafil formulation paired with pycnogenol.

A higher-dose sildenafil and bremelanotide combination for patients whose physician determines a stronger protocol is appropriate.

Combines two PDE5 inhibitors with different onset/duration profiles in a single dissolving tablet.

A three-active formulation combining dual PDE5 inhibition with apomorphine, a dopamine-receptor agonist, reserved for patients whose physician determines standard therapy is insufficient.

A four-active compounded formulation combining three PDE5 inhibitors at lower individual doses with apomorphine.

The entry-strength tier of MedFit's tri-active rapid-dissolve formula.

The mid-strength tier of MedFit's tri-active rapid-dissolve formula.

The highest-strength tier of MedFit's tri-active rapid-dissolve formula, reserved for patients whose physician determines it's appropriate after starting at a lower tier.

A compounded combination built around flibanserin, a medication that affects brain neurotransmitter balance to support sexual desire, alongside oxytocin and tyrosine.